KINOMED™ is a consortium supported by the Eurostars program of the European Union. The aim of KINOMED™ is the establishment of a structure-based drug design platform with a focus on protein kinases. The KINOMED™ consortium combines the expertise of SARomics Biostructures in computational chemistry, molecular modeling, X-ray crystallography and structure-based drug design target-specific libraries of small-molecule fragments for screening for fragment binding from IOTA Pharmaceuticals with the expertise from KinaseDetect in the areas of protein kinase function and biochemistry.
The services provided by the KINOMED™ consortium include:
• Protein production
• Kinase assay and characterization
• Co-crystallization with a customers ligand
• X-ray structure determination
• Fragment screening
• Crystallization in complex with fragments
Please contact us for the discussion of your project.